Back
Bill Holdings, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Buy
57
BILL
Bill Holdings, Inc.
Last Price:
$55.96
Seasonality Move:
-19.18%
Sell
46
NKTR
Nektar Therapeutics
Last Price:
$46.82
Seasonality Move:
6.44%
Buy
57
Bill Holdings, Inc. (BILL)
is a Buy
Is Bill Holdings, Inc. a Buy, Sell or Hold?
-
The current Bill Holdings, Inc. [BILL] share price is $55.98. The Score for BILL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
BILL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BILL Stock Price Chart
What is Bill Holdings, Inc.'s stock price today?
-
The Bill Holdings, Inc. share price today is $55.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BILL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $46.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
BILL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.44 | Buy |
| Relative Strength Index (14 RSI): | 65.76 | Buy |
| Chaikin Money Flow: | 3940993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.18 - 54.5) | Buy |
| Bollinger Bands (100): | (44.43 - 53.61) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.95 | Sell |
| Relative Strength Index (14 RSI): | 38.83 | Sell |
| Chaikin Money Flow: | 857593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.69 - 61.39) | Sell |
| Bollinger Bands (100): | (34.99 - 62.73) | Sell |
BILL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.71 | Buy |
| 20-day SMA: | 52.6 | Buy |
| 50-day SMA: | 50.61 | Buy |
| 200-day SMA: | 47.09 | Buy |
| 8-day EMA: | 54.48 | Buy |
| 20-day EMA: | 53.03 | Buy |
| 50-day EMA: | 51.31 | Buy |
| 200-day EMA: | 51.61 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.29 | Sell |
| 20-day SMA: | 55.51 | Sell |
| 50-day SMA: | 57.37 | Sell |
| 200-day SMA: | 31.53 | Buy |
| 8-day EMA: | 49.58 | Sell |
| 20-day EMA: | 53.48 | Sell |
| 50-day EMA: | 54.29 | Sell |
| 200-day EMA: | 38.34 | Buy |
Bill Holdings, Inc. Earnings Growth & BILL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.14 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
Bill Holdings, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||